Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Hodgkin lymphoma, Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1/2
This trial looked at BI-1206 to treat B cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2020. The team reported the results in 2021.
Recruitment start: 4 October 2016
Recruitment end: 27 March 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
BioInvent International AB
Blood Cancer UK (used to be called Bloodwise)
Cancer Research UK (trial sponsor - regulatory@cancer.org.uk)
The CRUK trial number is CRUKD/16/001.
There is more information about this trial on the clinicaltrials.gov website (NCT02933320):
Last reviewed: 08 Mar 2023
CRUK internal database number: 14371
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
